Walvax Biotechnology Co., Ltd. (SHE: 300142)
China flag China · Delayed Price · Currency is CNY
13.03
0.00 (0.00%)
Dec 18, 2024, 3:04 PM CST

Walvax Biotechnology Revenue

Walvax Biotechnology had revenue of 708.00M CNY in the quarter ending September 30, 2024, a decrease of -28.51%. This brings the company's revenue in the last twelve months to 3.10B, down -31.76% year-over-year. In the year 2023, Walvax Biotechnology had annual revenue of 4.11B, down -19.12%.

Revenue (ttm)
3.10B
Revenue Growth
-31.76%
P/S Ratio
6.75
Revenue / Employee
1.30M
Employees
2,388
Market Cap
20.92B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.11B-972.67M-19.12%
Jan 1, 20235.09B1.62B46.89%
Jan 1, 20223.46B523.81M17.82%
Dec 31, 20202.94B1.82B162.13%
Dec 31, 20191.12B246.90M28.24%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition